Document is current
Any future updates will be listed below
-
Authors
Zhang, Xiaofang
Peck, Carl C.
Wang, Yaning
Szucs, Thomas D.
Sun, Wan
Bai, Xue
Chen, Siyu
Wang, Fengzhi
Wu, Yangfeng https://orcid.org/0000-0002-4451-1932
- License Information
-
More Information
Article History
Received: 18 December 2023
Accepted: 27 November 2024
First Online: 18 December 2024
Declarations
:
: This study used publicly available information and did not require ethics approval from the Peking University Human Research Protection Program.
: Not applicable.
: In the past 36 months, XFZ and YFW received research support from the Peking University National Academy of Pharmaceutical and Medical Device Regulatory Sciences for the research on expedited programs. XFZ and YFW received research support from China Association of Enterprises with Foreign Investment R&D-based Pharmaceutical Association Committee for the research on Quality of Drug Clinical Trials in China and its Influence Factors and research support from China National Biotec Group (CNBG) for conducting researches in Peking University Health Science Center (PUHSC)—China National Biotec Group (CNBG) Joint Laboratory.
